Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa

Area of Science:

• Microbiology
• Pharmacology
• Biochemistry

Background:

• Pseudomonas aeruginosa is a significant bacterial pathogen forming biofilms, particularly in lung infections.
• Respiratory Pseudomonas biofilms contain anionic extracellular polymeric substances (EPS), like alginate and rhamnolipids, contributing to a mucoid phenotype.

Purpose of the Study:

• To investigate the efficacy of anionic fluoroquinolones in penetrating Pseudomonas aeruginosa EPS.
• To assess the growth inhibition of mucoid P. aeruginosa by anionic fluoroquinolones.
• To compare the drug penetration of anionic fluoroquinolones with standard antibiotics.

Main Methods:

• Utilized a novel microdiffusion assay.
• Evaluated drug penetration through purified pseudomonal alginate.
• Assessed drug penetration through respiratory mucus from cystic fibrosis patients.

Main Results:

• Anionic fluoroquinolones demonstrated the ability to traverse the EPS layer of Pseudomonas biofilms.
• The study provided comparative data on the penetration of anionic fluoroquinolones versus standard antibiotics.
• Efficacy was tested in relevant models including patient-derived cystic fibrosis mucus.

Conclusions:

• Anionic fluoroquinolones represent a promising therapeutic strategy for combating Pseudomonas aeruginosa biofilm infections.
• The findings suggest potential for improved antibiotic delivery across challenging biofilm structures in respiratory diseases.